SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. We have a team of investment professionals, located in the US and UK. As a Team, our experience spans basic science, industry and the market. We take an active role in our portfolio companies and work with management teams and our fellow venture investors to create significant value. Celebrating its 30th anniversary in 2015, SR One has invested $1B in more than 170 companies, and its current portfolio includes 40 private and public companies. Our expanded remit also focuses on maximizing the value of GSK technological innovation to establish new businesses and revenue opportunities across a range of industries.

Type
Investor
HQ
Cambridge, US
Founded
1985
Website
srone.com
SR One was founded in 1985 and is headquartered in Cambridge, US
Report incorrect company information

Key People/Management at SR One

Jens Eckstein

Jens Eckstein

President
Simeon George

Simeon George

Partner
Rajeev Dadoo

Rajeev Dadoo

Partner
Brian Gallagher

Brian Gallagher

Partner
Deborah Harland

Deborah Harland

Partner
Vikas Goyal

Vikas Goyal

Associate
Show more

SR One Office Locations

SR One has an office in Cambridge
Cambridge, US (HQ)
1 Broadway
Show all (1)
Report incorrect company information

SR One Investment Portfolio

Stage Distribution

20032018

Top Sectors Distribution

20032018

Round Size Distribution

20032018

SR One Company Life and Culture

Report incorrect company information